CHD9

RNA expression — cross-omics
Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, CHD9 RNA expression is significantly associated with the protein abundance of many other proteins, with 16,017 significant associations in total. GBM shows the largest number of these associations.

The most reproducible CHD9-associated proteins across cancer lineages are TERF2IP, PPL, and FTO. Each is linked with CHD9 in more than 4 cancer types. Because this analysis shows association rather than direction, both CHD9-to-partner and partner-to-CHD9 results are reported.

Each partner links to its own Q-omics profile. The scatter plot shows the strongest example, CHD9 versus TERF2IP in GBM, with a Pearson correlation of 0.50.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (CHD9→partner) and Y-score (partner→CHD9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMTERF2IP →+0.245+0.443<.001<.00135
BRCAPPL →+0.578+0.516<.001<.00135
GBMFTO →+0.310+0.399<.001<.00135
LUADRPL12_S38 →-0.893-0.433<.001<.00135
CCRCCRPL6 →-0.401-0.336<.001.00235
LUADNCL_S67 →-0.788-0.330<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest of 16,017 associations by consensus.

CHD9 vs TERF2IP — GBM

Per-sample scatter of CHD9 vs TERF2IP in GBM (Pearson r = 0.50).

Explore this scatter interactively →

Exploration